Angiotensin II for the Treatment of Vasodilatory Shock

The New England Journal of Medicine
Ashish KhannaATHOS-3 Investigators

Abstract

Vasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. We investigated the effectiveness of angiotensin II for the treatment of patients with this condition. We randomly assigned patients with vasodilatory shock who were receiving more than 0.2 μg of norepinephrine per kilogram of body weight per minute or the equivalent dose of another vasopressor to receive infusions of either angiotensin II or placebo. The primary end point was a response with respect to mean arterial pressure at hour 3 after the start of infusion, with response defined as an increase from baseline of at least 10 mm Hg or an increase to at least 75 mm Hg, without an increase in the dose of background vasopressors. A total of 344 patients were assigned to one of the two regimens; 321 received a study intervention (163 received angiotensin II, and 158 received placebo) and were included in the analysis. The primary end point was reached by more patients in the angiotensin II group (114 of 163 patients, 69.9%) than in the placebo group (37 of 158 patients, 23.4%) (odds ratio, 7.95; 95% confidence interval [CI], 4.76 to 13.3; P<0.001). At 48 hours, the mean improvement in the cardiovascular Sequential Organ Failure ...Continue Reading

References

Aug 1, 1991·Critical Care Medicine·V L Thomas, M S Nielsen
Dec 16, 1995·Lancet·G M Wray, J H Coakley
Dec 29, 1998·European Journal of Pharmacology·T InoueE K Jackson
May 9, 2000·Archives of Disease in Childhood·M Yunge, A Petros
Dec 26, 2001·Hypertension·N Basso, N A Terragno
Dec 9, 1961·JAMA : the Journal of the American Medical Association·F DEL GRECO, D C JOHNSON
Nov 1, 1941·The Journal of Clinical Investigation·S E Bradley, B Parker
Aug 2, 2006·Critical Care : the Official Journal of the Critical Care Forum·Paul W G Elbers, Can Ince
Mar 5, 2010·The New England Journal of Medicine·Daniel De BackerUNKNOWN SOAP II Investigators
Aug 23, 2012·Chest·Samuel M BrownAlan H Morris
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
Oct 11, 2013·JAMA : the Journal of the American Medical Association·Andrea MorelliMervyn Singer
Dec 18, 2013·Virulence·Florian B MayrDerek C Angus
Oct 8, 2014·Critical Care : the Official Journal of the Critical Care Forum·Lakhmir S ChawlaMichael G Seneff
Apr 19, 2015·Critical Care : the Official Journal of the Critical Care Forum·Thiago D CorrêaStephan M Jakob
Nov 24, 2016·Shock·Elio AntonucciSabino Scolletta

❮ Previous
Next ❯

Citations

Mar 28, 2018·The Annals of Pharmacotherapy·Brittany D BissellAlexander H Flannery
Mar 24, 2018·Emergency Medicine Australasia : EMA·Julian M WilliamsJohn F Fraser
Mar 22, 2018·Critical Care : the Official Journal of the Critical Care Forum·Anna HallMarlies Ostermann
Apr 25, 2018·Nature Reviews. Nephrology·Christophe Lelubre, Jean-Louis Vincent
Nov 9, 2017·The New England Journal of Medicine·Giovanni LandoniRinaldo Bellomo
Nov 28, 2017·Critical Care : the Official Journal of the Critical Care Forum·Kevin K ChungUNKNOWN Randomized controlled Evaluation of high-volume hemofiltration in adult burn patients with Septic shoCk and acUte kidnEy inj
Mar 7, 2018·Critical Care Medicine·James A TumlinUNKNOWN Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators
Nov 16, 2017·Critical Care : the Official Journal of the Critical Care Forum·Elio AntonucciYasser Sakr
Dec 29, 2017·Critical Care : the Official Journal of the Critical Care Forum·Laurence W BusseMarlies Ostermann
Dec 30, 2017·Critical Care : the Official Journal of the Critical Care Forum·Eleni VrigkouPetros Kopterides
Jun 8, 2018·Current Opinion in Critical Care·Brett J WakefieldAshish K Khanna
Dec 13, 2017·Anesthesiology·James A Russell
Jun 8, 2018·Pharmacotherapy·Seth R BauerSimon W Lam
Jun 30, 2018·Critical Care Medicine·Craig M CoopersmithAndrew Rhodes
Sep 2, 2017·Intensive Care Medicine·Jean-Louis TeboulJames A Russell
Jul 14, 2018·The American Journal of Nursing·Donna LesterAmanda Bennett
Jul 7, 2018·Critical Care Medicine·Francisco Vasques-NóvoaRoberto Roncon-Albuquerque
Apr 25, 2018·A&A Practice·Jonathan H ChowMichael T McCurdy
Sep 15, 2018·Critical Care Medicine·Richard Beale
Nov 10, 2018·Expert Review of Proteomics·Ana Belén SanzAlberto Ortiz
Dec 7, 2018·Pharmacotherapy·Mitchell S BuckleySandra L Kane-Gill
Nov 30, 2018·Journal of Cardiovascular Pharmacology·Antoine HerpainFabio Sangalli
Nov 28, 2018·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Linda A AllenJulian H Lombard
Jan 20, 2018·Critical Care : the Official Journal of the Critical Care Forum·David CoquerelOlivier Lesur
Jan 18, 2019·Critical Care Medicine·Ashish K Khanna
Jan 16, 2019·Pharmacotherapy·Gretchen L SachaIshaq Lat
Feb 12, 2019·Intensive Care Medicine·Daniel De BackerKeith R Walley
Feb 13, 2019·Internal Medicine Journal·Kelly ThompsonSimon Finfer
Mar 1, 2018·Critical Care : the Official Journal of the Critical Care Forum·Bruno LevyAntoine Kimmoun
Feb 16, 2019·Critical Care Medicine·Rinaldo BellomoGeorge F Tidmarsh
Feb 6, 2019·Current Opinion in Anaesthesiology·Mark E Nunnally, Arpit Patel
Nov 2, 2018·Critical Care : the Official Journal of the Critical Care Forum·Marlies OstermannKyle Gunnerson
Mar 8, 2018·Annals of Intensive Care·Gretchen L SachaSeth R Bauer
Jan 11, 2019·BMJ : British Medical Journal·Jason T Poston, Jay L Koyner
Jan 3, 2019·Cardiology in Review·Saira C Khalique, Nadia Ferguson
Apr 16, 2019·Seminars in Cardiothoracic and Vascular Anesthesia·Brigid C FlynnNatalia S Ivascu
Apr 18, 2019·Critical Care : the Official Journal of the Critical Care Forum·Lakhmir S ChawlaGeorge F Tidmarsh
Jun 15, 2017·Nature Reviews. Cardiology·Irene Fernández-Ruiz
Sep 5, 2017·Nature Reviews. Nephrology·Ying Wang, Rinaldo Bellomo
Dec 6, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Douglas A SimonettoPatrick S Kamath
Jul 12, 2019·Expert Review of Clinical Pharmacology·Jean-Louis Vincent, Yasser Sakr
Aug 8, 2018·Der Anaesthesist·C J ReußT Brenner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Anthony C GordonDeborah Ashby
The New England Journal of Medicine
Robert J MotzerCheckMate 025 Investigators
The New England Journal of Medicine
Rajendra H MehtaLEVO-CTS Investigators
The New England Journal of Medicine
Philip MeaseFUTURE 1 Study Group
The New England Journal of Medicine
Milton PackerTRUE-AHF Investigators
© 2022 Meta ULC. All rights reserved